Cardiovascular Business

The cardiovascular business channel offers news and new technologies to aid the business management of the cardiovascular service line.

The UCLA Department of Medicine has announced that Priscilla Hsue, MD will be joining as the chief of the Division of Cardiology at UCLA, effective July 1, 2024. Hsue will come to UCLA from UC San Francisco (UCSF), where she leads a portfolio of clinical and translational studies on HIV-related cardiovascular disease and Long COVID.
News | Cardiovascular Education
UCLA Health Selects Dr. Priscilla Hsue as Cardiology Division Chief

March 21, 2024 — The UCLA Department of Medicine has announced that Priscilla Hsue, MD will be joining as the chief of ...

Home March 21, 2024
Home
In a new letter sent to federal officials on March 12, the American Medical Association (AMA) has presented six relief proposals to support physicians impacted by Change Healthcare hack, and praised the creation of the Change Healthcare/Optum Payment Disruption (CHOPD) Accelerated Payments.
News | Cybersecurity
AMA Presents Relief Proposals to Federal Officials to Support Physicians Impacted by Change Healthcare Hack

March 14, 2024 — The American Medical Association (AMA) has issued a new letter to federal officials in which it praised ...

Home March 14, 2024
Home
New Jersey-based Atlantic Health System’s Morristown Medical Center and New York-based NYU Langone Health, both nationally recognized cardiovascular programs, have announced that they are expanding their partnership to provide patients improved access to adult congenital heart disease services and the specialist directed care. Shown here, Trish O’Keefe, Senior Vice President, and President of Morristown Medical Center.
News | Cardiovascular Business
Atlantic Health System’s Morristown Medical Center and NYU Langone Health Expand Partnership to Include Adult Congenital Heart Disease

March 13, 2024 — Two nationally recognized cardiovascular programs, New Jersey-based Atlantic Health System’s Morristown ...

Home March 13, 2024
Home
Silence Therapeutics has announces positive topline 36-week data from its ongoing Phase 2 Study of Zerlasiran in patients with high Lipoprotein(a), reporting that the study met the primary endpoint and demonstrated highly significant reductions in Lp(a) to week 36.
News | Cardiovascular Clinical Studies
Positive Topline 36-Week Data from Ongoing Phase 2 Study of Zerlasiran in Patients with High Lp(a) Announced by Silence Therapeutics

March 13, 2024 — Silence Therapeutics has announced positive topline 36-week data from the ongoing ALPACAR-360 phase 2 ...

Home March 13, 2024
Home
Getinge has announced the U.S. Food and Drug Administration’s (FDA) 510(k) clearance of the Vasoview Hemopro 3, the latest addition to the medtech company’s endoscopic vessel harvesting (EVH) solutions.
News | FDA
Getinge Announces US FDA 510(k) Clearance for Vasoview Hemopro 3 Endoscopic Vessel Harvesting (EVH) solution

March 12, 2024 — Getinge has announced the U.S. Food and Drug Administration’s (FDA) 510(k) clearance of the Vasoview ...

Home March 12, 2024
Home
VahatiCor, Inc., a med tech company dedicated to helping patients with persistent ischemic heart disease, has announced the treatment of the first patient with the A-FLUX Reducer System, a treatment for patients with angina or chest pain.
News | Cardiovascular Business
VahatiCor, Inc. Announces Treatment of First Patient with the A-FLUX Reducer System Innovation for Patients Suffering from Angina Due to Persistent Ischemic Heart Disease

March 11, 2024 — VahatiCor, Inc., a med tech company dedicated to helping patients with persistent ischemic heart ...

Home March 11, 2024
Home
Georgia Tech-led effort to improve support device options for end-stage heart failure
News | Heart Failure
The Texas Heart Institute Collaborates on Multi-institutional DOD Grant to Develop Novel Left Ventricular Assist Device

March 8, 2024 —  The Texas Heart Institute, Georgia Institute of Technology (Georgia Tech), North Carolina State ...

Home March 08, 2024
Home
An AMA letter sent to Secretary Bacerra outlines ongoing concerns of physicians amidst the cybersecurity incident that has impacted Change Healthcare
News | Cybersecurity
As Cyberattack Jeopardizes Physician Practices, AMA Demands Action

March 6, 2024 — As the cyber-takedown of Change Healthcare has forced medical practices to go without revenue for a ...

Home March 06, 2024
Home
Bodyport Inc., a biomarker-guided predictive care company, has presented data showing its FDA-cleared, non-invasive, biomarker-based technology for remote heart failure monitoring detected twice as many heart failure events as compared to the weight-based standard of care.
News | Cardiovascular Clinical Studies
Bodyport Presents Preliminary Analysis of SCALE-HF 1 Study on Remote Heart Failure Monitoring at Technology and Heart Failure Therapeutics (THT) Conference

March 6, 2024 — Bodyport Inc., a biomarker-guided predictive care company focused on heart failure, announced data from ...

Home March 06, 2024
Home
Hal Wolf, president and CEO of HIMSS
Feature
One on One ... with Hal Wolf, FHIMSS

Industry trade shows and conferences seem to be making their comeback. The Healthcare Information and Management Systems ...

Home March 06, 2024
Home
A look at DAIC's top-viewed content for February 2024
Feature | Cardiovascular Business | By Melinda Taschetta-Millane
A Look at February's Top 10

February was a short but busy month in the diagnostic and interventional cardiology world, with a lot of news being ...

Home March 05, 2024
Home
Health technology giant Royal Philips has announced its proposal to appoint Charlotte Hanneman as member of the Board of Management to fulfill the role of Chief Financial Officer (CFO), filling the position held by Abhijit Bhattacharya, who will be retiring at the end of September after in that role since 2015.
News | Cardiovascular Business
Philips Appoints Charlotte Hanneman to succeed Abhijit Bhattacharya as Chief Financial Officer (CFO)

February 28, 2024 — Royal Philips has announced the proposal to appoint Charlotte Hanneman as member of the Board of ...

Home February 28, 2024
Home
The DAIC team has learned of the passing of Alain Cribier, MD, FACC, heralded as the man who pioneered the first transcatheter aortic valve replacement (TAVR) in 2002
Feature | Cardiovascular Surgery
In Memoriam: Alain Cribier, MD, FACC, TAVR Pioneer

The DAIC team has learned of the passing of Alain Cribier, MD, FACC, heralded as the man who pioneered the first transca ...

Home February 23, 2024
Home
Ismail El-Hamamsy, MD, PhD, Director of Aortic Surgery for the Mount Sinai Health System and the Mount Sinai Randall B. Griepp, MD Professor in Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai, was named as the new President of the Heart Valve Society
News | Cardiovascular Business
Ismail El-Hamamsy, MD, PhD, Named President of the Heart Valve Society

February 22, 2024 — Ismail El-Hamamsy, MD, PhD, Director of Aortic Surgery for the Mount Sinai Health System and the Mou ...

Home February 22, 2024
Home
Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a subsidiary of Bayer AG, have announced that the first patient has been randomized in GenePHIT (Gene PHosphatase Inhibition Therapy), a Phase II trial of AB-1002, also known as NAN-101, for the treatment of congestive heart failure (CHF).
News | Cardiovascular Clinical Studies
First Patient Randomized in AskBio Phase II Gene Therapy Trial for Congestive Heart Failure Treatment

February 15, 2024 — Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and ...

Home February 15, 2024
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now